Controlling Clinical Trials Labeling on a Global Scale
PRISYM ID Clinical Trials Labeling experts share their advice on how to manage source data, local language labeling and country specific requirements.
Clinical trials are a global activity with clinical trial materials being shipped across many countries and many continents. For the sake of patient safety, the ability to control these materials’ labels at a global level is paramount. Labeling, booklets and where necessary IFUs (Instructions for Use) must therefore be safely and accurately customized not only so that they are in the appropriate local languages, but also ensure country specific nuances of including country specific designs and regulatory requirements are understood sufficiently to communicate coherently with users.
In this 60-minute, information-packed session, PRISYM ID explores what the industry can do to improve data security and mitigate risks involved in clinical trial local language labeling and country specific design.
Benefits of Viewing:
- Gain an understanding of global clinical trials labeling in practical terms
- Understand how labeling systems can remove the perceived complexities of local language labeling
- Realize how to manage source data for labels, booklets and IFUs
- Learn how to customize labels for country specific requirements